Cargando…
MACC1 decreases the chemosensitivity of gastric cancer cells to oxaliplatin by regulating FASN expression
The effect of chemotherapeutic agents is limited as a result of drug resistance, which demands prompt solutions provided by clinical studies. To date, the underlying mechanisms of chemotherapy resistance are relatively unknown. Metastasis-associated in colon cancer 1 (MACC1) is an oncogene associate...
Autores principales: | Duan, Jiangman, Chen, Lishan, Zhou, Minyu, Zhang, Jingwen, Sun, Li, Huang, Na, Bin, Jianping, Liao, Yulin, Liao, Wangjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428767/ https://www.ncbi.nlm.nih.gov/pubmed/28339092 http://dx.doi.org/10.3892/or.2017.5519 |
Ejemplares similares
-
MACC-1 Promotes Endothelium-Dependent Angiogenesis in Gastric Cancer by Activating TWIST1/VEGF-A Signal Pathway
por: Wang, Lin, et al.
Publicado: (2016) -
MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling
por: Huang, Na, et al.
Publicado: (2015) -
Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer
por: SU, YUQI, et al.
Publicado: (2015) -
Gastric cancer cells escape metabolic stress via the DLC3/MACC1 axis
por: Lin, Li, et al.
Publicado: (2019) -
Depression accelerates gastric cancer invasion and metastasis by inducing a neuroendocrine phenotype via the catecholamine/β(2)‐AR/MACC1 axis
por: Pan, Changqie, et al.
Publicado: (2021)